James A. Bonner

Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck

James A. Bonner, Paul M. Harari, J. Giralt et al. · New England Journal of Medicine · 2006 · 5.1K citations · Full text

Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival

James A. Bonner, Paul M. Harari, J. Giralt et al. · The Lancet Oncology · 2009 · 2K citations

Advanced Head, Neck Cancer, Radiation Therapy +9

Randomized Phase III Trial of Concurrent Accelerated Radiation Plus Cisplatin With or Without Cetuximab for Stage III to IV Head and Neck Carcinoma: RTOG 0522

K. Kian Ang, Qiang Zhang, David I. Rosenthal et al. · Journal of Clinical Oncology · 2014 · 821 citations · Full text

Phase I Study of Anti–Epidermal Growth Factor Receptor Antibody Cetuximab in Combination With Radiation Therapy in Patients With Advanced Head and Neck Cancer

Francisco Robert, Mark P. Ezekiel, Sharon A. Spencer et al. · Journal of Clinical Oncology · 2001 · 473 citations

Patterns of Surgical Care of Lung Cancer Patients

Alex G. Little, Valerie W. Rusch, James A. Bonner et al. · The Annals of Thoracic Surgery · 2005 · 433 citations · Full text